Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Venture
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Acasti Pharma Inc

+ Add to Watchlist

APO:CN

0.4250 CAD 0.0050 1.16%

As of 15:55:01 ET on 05/22/2015.

Snapshot for Acasti Pharma Inc (APO)

Open: 0.4300 Day's Range: 0.4000 - 0.4300 Volume: 53,320
Previous Close: 0.4300 52wk Range: 0.4000 - 1.3000 1-Yr Rtn: -55.73%

Stock Chart for APO

No chart data available.
  • APO:CN 0.4250
  • 1D
  • 1M
  • 1Y
0.4300
Interactive APO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for APO

Current P/E Ratio (ttm) -
Estimated P/E(02/2014) -
Relative P/E vs. SPTSX -
Earnings Per Share (CAD) (ttm) -0.1200
Est. EPS (CAD) (02/2014) -0.1100
Est. PEG Ratio -
Market Cap (M CAD) 45.24
Shares Outstanding (M) 106.44
30 Day Average Volume 37,406
Price/Book (mrq) 1.5516
Price/Sale (ttm) 42.2976
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for APO

No data available

Company Profile & Key Executives for APO

Acasti Pharma Inc is a pharmaceutical company. The Company develops drugs for cardiovascular diseases. Acasti offers omega-3 phospholipids a major component of cell membranes.

Pierre LemieuxChief Operating OfficerTina SampalisChief Global Strategy Ofcr
Harlan W WaksalVP:Business & Scientific
More Company Profile & Key Executives for APO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil